UK adopts military technology adapted to diagnose chlamydia:
This article was originally published in Clinica
Executive Summary
The UK treasury is giving the Porton Down branch of the Department of Science and Technology Laboratory (Dstl) and the Department of Health £4.6m ($6.6m) to provide hospital labs and clinics with a chlamydia screening device that Dstl has created by adapting existing military technology. The technology, initially designed to track biological warfare agents, will enable the NHS to obtain accurate results within 40 minutes compared with the previous standard of a fortnight, thus saving the NHS "millions", claims Dstl. Chlamydia affects 10% of women aged between 16 and 24.
You may also be interested in...
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.